GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles

被引:3
|
作者
Zhai, Xiang-Hong [1 ,2 ]
Zhang, Ping [2 ,3 ]
Wu, Feng-Xia [4 ]
Wang, An-Cong [2 ,3 ]
Liu, Pei-Shu [5 ]
机构
[1] Linyi Peoples Hosp, Dept Obstet & Gynecol, Linyi Hlth Sch, Linyi 276003, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Dept Resp Med, 27 Jiefang Rd, Linyi 276003, Shandong, Peoples R China
[3] Linyi Peoples Hosp, Dept Obstet & Ginecol, Linyi 276003, Shandong, Peoples R China
[4] Shandong Univ, Dept Anat, Jinan 250012, Shandong, Peoples R China
[5] Shandong Univ, Qilu Hosp, Dept Obstet & Ginecol, Jinan 250012, Shandong, Peoples R China
关键词
polycystic ovary syndrome; in vitro fertilization and embryo transfer; gonadotrophin-releasing hormone antagonist; ovarian hyperstimulation syndrome; clinical pregnancy; fresh cycle; ENDOMETRIAL RECEPTIVITY; ANALOG; IVF; GONADOTROPINS; METAANALYSIS; THICKNESS;
D O I
10.3892/etm.2017.4309
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to evaluate the influence of a gonadotropin-releasing hormone (GnRH) antagonist compared with a GnRH agonist on the in vitro fertilization cycle outcome in patients with polycystic ovary syndrome. The outcomes of pregnancy were evaluated. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was also used to evaluate whether the endometrial thickness (cm) and estradiol (E-2) level (pg/ml) on the day of human chorionic gonadotropin (hCG) administration (the hCG day) had the best sensitivity and specificity for predicting a clinical pregnancy. The results demonstrated that there were significant differences in the E-2 and progesterone levels between the two treatment groups on the hCG day. Furthermore, the mean number of total oocytes retrieved, mean number of 2 pronuclei oocytes, mean number of oocytes cleaved (P< 0.05), mean number of embryos available (P= 0.022) and mean number of embryos transferred (P= 0.014) were significantly different. Additionally, the rates of ectopic pregnancy (P= 0.984) and ovarian hyperstimulation syndrome (P= 0.976) did not differ significantly between the treatment groups. Although the biochemical pregnancy (P= 0.592), clinical pregnancy (P= 0.617) and live birth (P= 0.365) rates were lower with the GnRH antagonist than with the GnRH agonist, there were no significant differences in the outcomes between the two groups. Analysis of the influence of endometrial thickness with respect to the clinical pregnancy using the ROC (AUC) method revealed that when the best cutoff of 9.75 cm was used, the sensitivity was 62.5%, the specificity was 43.1% and the AUC was 0.53. Additionally, the Youden index was 0.056. Analysis of the influence of the E-2 level on the hCG day on clinical pregnancy, using the ROC (AUC) method showed that the best cutoff was 2,984.5 pg/ml, which had a sensitivity of 68.8% and specificity of 52.9%, while the AUC was 0.573 (with a Youden index of 0.217). Furthermore, the results demonstrated that neither the endometrial thickness nor the E-2 level on the hCG day had the best sensitivity and specificity for predicting a clinical pregnancy.
引用
收藏
页码:3097 / 3102
页数:6
相关论文
共 50 条
  • [1] What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
    Orvieto, Raoul
    Meltcer, Simion
    Homburg, Roy
    Nahum, Ravit
    Rabinson, Jacob
    Ashkenazi, Jacob
    FERTILITY AND STERILITY, 2009, 91 (04) : 1466 - 1468
  • [2] Influence of GnRH antagonist in reproductive women on in vitro fertilization and embryo transfer in fresh cycles
    Xu, Yang
    Zhang, Yu-Song
    Zhu, Dong-Yi
    Zhai, Xiang-Hong
    Wu, Feng-Xia
    Wang, An-Cong
    BIOMEDICAL REPORTS, 2019, 10 (02) : 113 - 118
  • [3] REPRODUCTIVE OUTCOMES IN POLYCYSTIC OVARY SYNDROME (PCOS) PATIENTS UNDERGOING GONADOTROPIN-RELEASING HORMONE (GNRH) AGONIST AND GNRH ANTAGONIST IN VITRO FERTILIZATION (IVF) CYCLES
    Clapp, M. A.
    Kudesia, R.
    Lieman, H.
    FERTILITY AND STERILITY, 2015, 104 (03) : E128 - E129
  • [4] Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles
    Orvieto, R
    Yulzari-Roll, V
    La Marca, A
    Ashkenazi, J
    Fisch, B
    GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (04) : 218 - 222
  • [5] Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer
    Doldi, Nicola
    Persico, Paola
    Di Sebastiano, Francesca
    Marsiglio, Elena
    Ferrari, Augusto
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (05) : 235 - 238
  • [6] Association of antimullerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer
    Liu, Su
    Hong, Ling
    Mo, Meilan
    Xiao, Shan
    Wang, Xuejin
    Fan, Xinfeng
    Zhang, Sainan
    Diao, Lianghui
    Zeng, Yong
    BMC PREGNANCY AND CHILDBIRTH, 2022, 22 (01)
  • [7] Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome
    Chen, Yilu
    Zhao, Junzhao
    Zhang, Huina
    MEDICAL SCIENCE MONITOR, 2018, 24 : 9424 - 9428
  • [8] Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial
    Palomba, Stefano
    Falbo, Angela
    Carrillo, Laura
    Villani, Maria Teresa
    Orio, Francesco
    Russo, Tiziana
    Di Cello, Annalisa
    Cappiello, Fulvio
    Capasso, Sabina
    Tolino, Achille
    Colao, Annamaria
    Mastrantonio, Pasquale
    La Sala, Giovanni Battista
    Zullo, Fulvio
    Cittadini, Ettore
    FERTILITY AND STERILITY, 2011, 96 (06) : 1384 - U369
  • [9] Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer
    Lin Hai-Yan
    Li Yu
    Wang Wen-Jun
    Qiu Qi
    Zhang Qing-Xue
    Li Yi
    中华医学杂志英文版, 2019, 132 (12) : 1448 - 1453
  • [10] Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer
    Lin, Hai-Yan
    Li, Yu
    Wang, Wen-Jun
    Qiu, Qi
    Zhang, Qing-Xue
    Li, Yi
    CHINESE MEDICAL JOURNAL, 2019, 132 (12) : 1448 - 1453